The Effects of Bromelain Supplement in Patients With Ulcerative Colitis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
In this study, patients with active mild to moderate UC with or without PSC will be randomized to receive either bromlein or placebo along with low FODMAP diet for 8 weeks. IBDQ, SCCAIQ, CRP, TAC, TNF-a will be measured before and after the intervention.
Epistemonikos ID: d60068268f290a63eb1eebe6e1354a5415060194
First added on: May 15, 2024